Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Allergic asthma: UFZ researchers identify a key molecule

12.10.2015

Allergies are becoming more commonplace, particularly in industrialised coun-tries. In addition to hay fever, allergic asthma is currently considered to be one of the most widespread allergies. UFZ researchers and their colleagues from the University of Leipzig have recently been successful in finding a protein that plays a critical role in the development of allergic airway inflammation. The discovery could pave the way for new therapies, as it also influences the pro-gression of the allergy.

Worldwide, there are more than 300 million asthma patients. In Germany alone, 10 - 15 percent of children suffer from allergic asthma that is often impaired by environmental pollutants. With the medications available today, symptoms can be effectively relieved, but without tackling the root cause. The precise reasons as to why certain people suffer from allergic asthma are still not fully clear.


It is still not fully clear as to why so many people today suffer from allergic asthma. Researchers from the UFZ and the University of Leipzig have now been successful in discovering a molecule that plays a significant role in the development of allergic asthma.

Photo: Alexander Raths, fotolia

Tobias Polte and his team from the Department of Environmental Immunology at the Helmholtz Centre for Environmental Research (UFZ) collaborated with Jan Simon and his colleagues from the Clinic for Dermatology, Venereology and Allergology at the University of Leipzig and have recently been successful in discovering a molecule that plays a significant role in the development of allergic airway inflammation - as demonstrated in their recent publication in Nature Communications.

The protein syndecan-4 is found in the cell membrane of antigen presenting cells (APCs). These are immune cells that detect exogenous substances (antigens). They internalize them and migrate to the nearest lymph node, where they present them to other immune cells, namely T-cells.

In this way they initiate an immune reaction that leads to sensitization to a particular antigen, like for example to a pollen allergen. It is upon renewed contact with this pollen allergen that the typical symptoms of allergic asthma arise.

"In our study we were able to demonstrate that syndecan-4 plays a critical role in APC migration", says Polte. "When syndecan-4 is lacking, the APCs cannot find their way to the T-cells and consequently cannot activate them. As a result, the immune reaction cannot take place and the sensitization to a particular antigen ceases."

Through investigations at the University of Leipzig, the researchers were also able to show that syndecan-4 in the APCs also plays a central role in the inflammatory process of allergic asthma: the allergic asthma symptoms of mice improved when they were given antibodies against syndecan-4. "In principle, syndecan-4 would be a good starting point for new therapies", says Polte.

"Since it exhibits various other functions in cell metabolism, potential side effects are still difficult to assess." To relieve the symptoms of patients with allergic asthma, the treatment of allergic airway inflammation with glucocorticoids and the use of a bronchodilator asthma spray will continue to be paramount in the near future.

"There will only be an effective therapy that gets to the root cause when we have fully understood the relationships behind the development of allergic asthma", says Polte. "Nevertheless, in our study we were able to discover an important component with syndecan-4 that should help us on the road to identifying new therapies."

Publication:
Polte T, Petzold S, Bertrand J, Schütze N, Hinz D, Simon JC, Lehmann I, Echtermeyer F, Pap T, Averbeck M. Critical role for syndecan-4 in dendritic cell migration during development of allergic airway inflammation Nature Communications 2015 Jul 13;6:7554. http://dx.doi.org/10.1038/ncomms8554
The study was funded by the Helmholtz Community and the Leipzig Research Centre for Civilization Diseases (LIFE).


Contact
Dr. Tobias Polte
Head of the Young Investigators Group LIPAD in the Department of Environmental Immunology Helmholtz Centre for Environmental Research – (UFZ)
phone: +49 341 235 1545
http://www.ufz.de/index.php?de=17308

Prof. Dr. Jan Simon
University Hospital Leipzig (Institution under Public Law) Clinic for Dermatology, Venereology and Allergology
phone: +49 341 97 18603


Contact Media
Susanne Hufe
UFZ press office
Tel. +49 - 341 - 235-1630
www.ufz.de/index.php?en=640


Address
Helmholtz Centre for Environmental Research - UFZ
Permoserstraße 15
04318 Leipzig
Germany
www.ufz.de


In the Helmholtz Centre for Environmental Research (UFZ), scientists conduct research into the causes and consequences of far-reaching environmental changes. Their areas of study cover water resources, biodiversity, the consequences of climate change and possible adaptation strategies, environmental technologies and biotechnologies, bio-energy, the effects of chemicals in the environment and the way they influence health, modelling and social-scientific issues. Its guiding principle: Our research contributes to the sustainable use of natural resources and helps to provide long-term protection for these vital assets in the face of global change. The UFZ employs more than 1,100 staff at its sites in Leipzig, Halle and Magdeburg. It is funded by the federal government, Saxony and Saxony-Anhalt. www.ufz.de


The Helmholtz Association contributes to solving major and urgent issues in society, science and industry through scientific excellence in six research areas: Energy, earth and environment, health, key technologies, structure of matter as well as aviation, aerospace and transportation. The Helmholtz Association is the largest scientific organisation in Germany, with 37,000 employees in 18 research centres and an annual budget of around €4 billion. Its work is carried out in the tradition of the great natural scientist Hermann von Helmholtz (1821-1894). www.helmholtz.de

UFZ Pressestelle | Helmholtz Centre for Environmental Research (UFZ),

More articles from Health and Medicine:

nachricht New combination therapy established as safe and effective for prostate cancer
26.06.2019 | Society of Nuclear Medicine and Molecular Imaging

nachricht Novel model for studying intestinal parasite could advance vaccine development
26.06.2019 | University of Pennsylvania

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fraunhofer IDMT demonstrates its method for acoustic quality inspection at »Sensor+Test 2019« in Nürnberg

From June 25th to 27th 2019, the Fraunhofer Institute for Digital Media Technology IDMT in Ilmenau (Germany) will be presenting a new solution for acoustic quality inspection allowing contact-free, non-destructive testing of manufactured parts and components. The method which has reached Technology Readiness Level 6 already, is currently being successfully tested in practical use together with a number of industrial partners.

Reducing machine downtime, manufacturing defects, and excessive scrap

Im Focus: Successfully Tested in Praxis: Bidirectional Sensor Technology Optimizes Laser Material Deposition

The quality of additively manufactured components depends not only on the manufacturing process, but also on the inline process control. The process control ensures a reliable coating process because it detects deviations from the target geometry immediately. At LASER World of PHOTONICS 2019, the Fraunhofer Institute for Laser Technology ILT will be demonstrating how well bi-directional sensor technology can already be used for Laser Material Deposition (LMD) in combination with commercial optics at booth A2.431.

Fraunhofer ILT has been developing optical sensor technology specifically for production measurement technology for around 10 years. In particular, its »bd-1«...

Im Focus: The hidden structure of the periodic system

The well-known representation of chemical elements is just one example of how objects can be arranged and classified

The periodic table of elements that most chemistry books depict is only one special case. This tabular overview of the chemical elements, which goes back to...

Im Focus: MPSD team discovers light-induced ferroelectricity in strontium titanate

Light can be used not only to measure materials’ properties, but also to change them. Especially interesting are those cases in which the function of a material can be modified, such as its ability to conduct electricity or to store information in its magnetic state. A team led by Andrea Cavalleri from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg used terahertz frequency light pulses to transform a non-ferroelectric material into a ferroelectric one.

Ferroelectricity is a state in which the constituent lattice “looks” in one specific direction, forming a macroscopic electrical polarisation. The ability to...

Im Focus: Determining the Earth’s gravity field more accurately than ever before

Researchers at TU Graz calculate the most accurate gravity field determination of the Earth using 1.16 billion satellite measurements. This yields valuable knowledge for climate research.

The Earth’s gravity fluctuates from place to place. Geodesists use this phenomenon to observe geodynamic and climatological processes. Using...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on UV LED Technologies & Applications – ICULTA 2020 | Call for Abstracts

24.06.2019 | Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

 
Latest News

Shell increases versatility of nanowires

26.06.2019 | Materials Sciences

Hubble finds tiny 'electric soccer balls' in space, helps solve interstellar mystery

26.06.2019 | Physics and Astronomy

New combination therapy established as safe and effective for prostate cancer

26.06.2019 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>